Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades T2 Biosystems to Neutral

BTIG Downgrades T2 Biosystems to Neutral

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Analyst Ratings

Where Lumentum Holdings Stands With Analysts

By Benzinga Insights

December 2, 1:02 PM

Over the past 3 months, 11 analysts have published their opinion on Lumentum Holdings (NASDAQ:LITE) stock. These analysts…

LITE

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points

By Lisa Levin

November 14, 11:38 AM

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

ARDX

Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

June 14, 8:19 AM

Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in today’s pre-market trading following better-than-expected second-quarter earnings and strong guidance.…

ADBE

Market Analysis: Salesforce And Competitors In Software Industry

By Benzinga Insights

April 17, 11:00 AM

In today’s rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to…

CRM

BTIG Downgrades T2 Biosystems to Neutral

Related Posts

Where Lumentum Holdings Stands With Analysts

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points

Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Market Analysis: Salesforce And Competitors In Software Industry